ストックスクリーナーアプリを入手
0.00
100.00%
-0.0179
前日終値:
$0.0179
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$0.0698
Nls Pharmaceutics Ag Stock (NLSPW) Company Profile
NLSPW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NLSPW
Nls Pharmaceutics Ag
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nls Pharmaceutics Ag (NLSPW) 最新ニュース
Is NLS Pharmaceutics AG stock supported by innovation pipeline2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Is NLS Pharmaceutics AG Equity Warrant stock a dividend growth opportunity2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - newser.com
Should you wait for a breakout in NLS Pharmaceutics AGJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - newser.com
Will NLS Pharmaceutics AG continue its uptrendEarnings Miss & Weekly Watchlist of Top Performers - newser.com
Is NLS Pharmaceutics AG Equity Warrant stock near bottom after declinePortfolio Risk Summary & Growth Focused Stock Reports - newser.com
Heatmap analysis for NLS Pharmaceutics AG Equity Warrant and competitorsPrice Action & Expert Curated Trade Ideas - newser.com
Published on: 2025-11-13 10:11:09 - newser.com
What to do if you’re stuck in NLS Pharmaceutics AG Equity WarrantPortfolio Value Report & Accurate Buy Signal Notifications - newser.com
What the charts say about NLS Pharmaceutics AG todayQuarterly Profit Summary & High Accuracy Investment Entry Signals - newser.com
Applying big data sentiment scoring on NLS Pharmaceutics AG Equity WarrantTrade Entry Report & AI Enhanced Trading Alerts - newser.com
Will NLS Pharmaceutics AG Equity Warrant continue its uptrend2025 Analyst Calls & Reliable Trade Execution Plans - newser.com
Is NLS Pharmaceutics AG Equity Warrant building a consolidation baseQuarterly Profit Summary & Fast Momentum Entry Tips - newser.com
Sentiment analysis tools applied to NLS Pharmaceutics AG Equity WarrantWeekly Gains Report & Stepwise Entry/Exit Trade Alerts - newser.com
NLS Pharmaceutics AG stock trend forecastJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
Real time scanner hits for NLS Pharmaceutics AG Equity Warrant explainedJuly 2025 Fed Impact & Advanced Technical Analysis Signals - newser.com
What candlestick patterns are forming on NLS Pharmaceutics AGJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - newser.com
Can NLS Pharmaceutics AG Equity Warrant recover in the next quarter2025 Retail Activity & High Return Stock Watch Alerts - newser.com
What margin trends mean for NLS Pharmaceutics AG stockWeekly Risk Report & Free Verified High Yield Trade Plans - newser.com
Will NLS Pharmaceutics AG Equity Warrant stock benefit from commodity pricesJuly 2025 PostEarnings & Weekly Market Pulse Alerts - newser.com
Is NLS Pharmaceutics AG stock affected by interest rate hikesEarnings Trend Report & Weekly Breakout Watchlists - newser.com
Analyzing NLS Pharmaceutics AG Equity Warrant with multi timeframe chartsJuly 2025 Opening Moves & Community Driven Trade Alerts - newser.com
Head to Head Contrast: NLS Pharmaceutics (NASDAQ:NCEL) vs. Addex Therapeutics (NASDAQ:ADXN) - Defense World
Short interest data insights for NLS Pharmaceutics AG Equity WarrantJuly 2025 Summary & Accurate Technical Buy Alerts - newser.com
What’s the recovery path for long term holders of NLS Pharmaceutics AGGap Up & Weekly Return Optimization Plans - newser.com
Nls Pharmaceutics Ag (NLSPW) 財務データ
Nls Pharmaceutics Ag (NLSPW) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.35%
0.75%
大文字化:
|
ボリューム (24 時間):